Lotus Biotech Development Corp.
CIK 0001520592
Revenue (TTM)
—
Q2 Sep 2016
Net Income (TTM)
−$15.17K
−4,071.7% YoY
Q2 Sep 2016
EPS Diluted (TTM)
—
Q2 Sep 2016
Gross Margin
—
Q2 Sep 2016
Operating Margin
—
Q2 Sep 2016
Net Margin
—
Q2 Sep 2016
Free Cash Flow (TTM)
—
Q2 Sep 2016
Cash
$1
Q2 Sep 2016
Total Debt
—
Q2 Sep 2016
Shares Outstanding
81.28M sh
Q2 Sep 2016
Revenue & Net Income
Cash Flow
Revenue Growth (YoY)
No data available for this metric.